Medicine
Pathogenesis of Autoimmune Thyroiditis and Hypothyroidism
Quick fact
Hashimoto's thyroiditis is the most common cause of hypothyroidism in iodine-rich countries, affecting up to 5% of the population, and is 5-10 times more common in women than men.
Why this is interesting
Your own immune system can slowly destroy your thyroid gland, and you might not notice until decades later. Why does the body attack itself, and what happens when it does?
Read the full explanation
Understanding Pathogenesis of Autoimmune Thyroiditis and Hypothyroidism
Imagine your thyroid gland as a busy hormone factory producing thyroid hormones (T3 and T4) that regulate your metabolism. In autoimmune thyroiditis, something goes wrong with the immune system's 'self-recognition' system – it mistakes parts of your thyroid as foreign invaders. The immune system then launches an attack on the gland, much like it would attack a virus or bacteria. This attack involves both B cells (which produce antibodies against thyroid proteins) and T cells (which directly kill thyroid cells). Over time, this chronic assault damages the thyroid tissue, reducing its ability to produce hormones. When the damage exceeds the gland's regenerative capacity, blood levels of thyroid hormones fall, leading to hypothyroidism – a state of slowed metabolism. This process is usually gradual, and symptoms like fatigue, weight gain, and cold intolerance often develop slowly over years.
A deeper explanation
The pathogenesis involves a complex interplay of genetic susceptibility and environmental triggers that break immune tolerance. Genetic factors, particularly certain HLA haplotypes and variants in immune-regulatory genes like CTLA-4 and PTPN22, predispose individuals to lose self-tolerance. Environmental factors such as high iodine intake, infections, stress, and pregnancy can trigger disease onset in susceptible individuals. The central mechanism is the activation of autoreactive CD4+ T cells that recognize thyroid-specific antigens like thyroperoxidase (TPO) and thyroglobulin. These T cells then orchestrate an immune response that includes: (1) activation of B cells to produce autoantibodies (anti-TPO and anti-thyroglobulin), which can cause antibody-dependent cell-mediated cytotoxicity and complement activation; (2) recruitment of CD8+ cytotoxic T cells that directly kill thyroid follicular cells via perforin and granzyme; (3) release of inflammatory cytokines (e.g., IFN-gamma, TNF) that promote further inflammation and fibrosis. The thyroid gland becomes infiltrated with lymphocytes, forming germinal centers, and over time the normal architecture is replaced by damaged tissue and fibrous scar, leading to gland atrophy and ultimately insufficient hormone synthesis. This explains the typical clinical progression from a euthyroid state to subclinical, then overt hypothyroidism. Understanding this pathway is crucial because it not only explains disease mechanism but also highlights why levothyroxine replacement (rather than immune suppression) is the mainstay of therapy once the gland is largely destroyed.